CV Sciences (CVSI) Cash from Investing Activities (2013 - 2026)

CV Sciences' (CVSI) quarterly Cash from Investing Activities came in at -$3000.0 in Q1 2026, up 92.5% year-on-year from -$1558.4 in Q1 2025, and up 66.67% quarter-over-quarter from -$9000.0 in Q4 2025.

CV Sciences (CVSI) Cash from Investing Activities (2013 - 2026) Analysis & Trends

CV Sciences has disclosed Cash from Investing Activities across 13 years of filings, most recently posting -$3000.0 for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$3000.0, up 92.5% year-over-year; the trailing twelve-month figure through Mar 2026 was -$72000.0 (down 5.88% YoY), and the FY2025 annual result was -$109000.0, down 289.29% from the prior year.
  • Cash from Investing Activities came in at -$3000.0 for Q1 2026 at CV Sciences, up from -$9000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $34000.0 in Q3 2024 to a low of -$156000.0 in Q4 2023.
  • The 4-year median for Cash from Investing Activities is -$22000.0 (2024), against an average of -$32888.9.
  • Across the five-year window, Cash from Investing Activities plunged 132.35% in 2025 and jumped 92.5% in 2026, its largest moves.
  • CV Sciences' Cash from Investing Activities stood at -$156000.0 in 2023, then surged by 85.9% to -$22000.0 in 2024, then soared by 59.09% to -$9000.0 in 2025, then jumped by 66.67% to -$3000.0 in 2026.
  • The last three Cash from Investing Activities figures came in at -$3000.0 (Q1 2026), -$9000.0 (Q4 2025), and -$11000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -2.08 Bn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 25.99 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -15.45 Mn
10 CV Sciences - - 1.56 Mn -3,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,000.00
Mar 31, 2026 -3,000.00
Dec 31, 2025 -9,000.00
Dec 31, 2025 -9,000.00
Sep 30, 2025 -11,000.00
Sep 30, 2025 -11,000.00
Jun 30, 2025 -49,000.00
Jun 30, 2025 -49,000.00
Mar 31, 2025 -40,000.00
Mar 31, 2025 -40,000.00
Dec 31, 2024 -22,000.00
Dec 31, 2024 -22,000.00
Sep 30, 2024 34,000.00
Sep 30, 2024 34,000.00
Jun 30, 2024 -40,000.00
Jun 30, 2024 -40,000.00
Dec 31, 2023 -156,000.00
Dec 31, 2023 -156,000.00
Mar 31, 2021 -35,000.00
Mar 31, 2021 -35,000.00